The level of prolactin in patient with CKD V stage, which are treated with hemodialysis
Journal Title: УКРАЇНСЬКИЙ ЖУРНАЛ НЕФРОЛОГІЇ ТА ДІАЛІЗУ - Year 2018, Vol 3, Issue 59
Abstract
The prevalence of hyperprolactinemia in patients treated with hemodialysis (HD) is 30-65%. Aim of our work was to investigate the prolactin (PL) level in patients treated with hemodialysis. Methods. An open prospective, non-randomized study it was involved 43 patients with CKD in the VD stage treated with hemodialysis. Criteria for inclusion of patients in the study were: informed consent of the patient to participate in the study, treatment of HD for more than three months, Kt / V> 1,2; vascular access - AV-fistula. The exclusion criteria were: refusal of the patient to participate in the study, liver cirrhosis, acute hepatitis B, C, hypothyroidism, acute coronary syndrome, stroke, pregnancy, patients with malignant neoplasms; those who systemically receive medications such as tricyclic antidepressants, monoamine oxidase inhibitors, reserpine, methyldopa, phenothiazine derivatives, antiemetic drugs (zocrama metoclopramide), dopamine synthesis inhibitors, and antipsychotics. All patients were evaluated for PL in serum. Results. Patients treated with HD have reported an elevated PL level in 32 (74%) patients. The level of serum PL in patients treated with HD was higher compared to the control group: 47.17 ± 32.4 versus 11.76 ± 4.33 ng/ml (p <0.001). The violation of the menstrual cycle was 85% in the group of women with elevated PL compared with 20% in women with normal PL (p <0,05). In groups of women and men with elevated PL level, the Hb level was significantly lower (p <0,05). It was established that the level of TL had a negative correlation with the level of Hb (r = -0,36; p = 0,02) and a positive correlation between the level of TL and CRP (r = 0,32; p = 0,03). Conclusions. The prevalence of hyperprolactinemia in our study was 74%. Violations of the menstrual cycle were significantly more common in women with hyperprolactinemia (85% vs. 20%). The increase in the concentration of PL has a negative correlation with the level of Hb and a positive correlation with the level of CRP, which suggests the involvement of PB in the processes of chronic inflammation
Authors and Affiliations
I. Dudar, V. Savchuk, O. Loboda, Yu. I. Gonchar
Keywords
Related Articles
- EP ID EP414697
- DOI 10.31450/ukrjnd.3(59).2018.06
- Views 77
- Downloads 0
СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ О ФАКТОРАХ РАЗВИТИЯ СИНДРОМА БЕЛКОВО-ЭНЕРГЕТИЧЕСКОЙ НЕДОСТАТОЧНОСТИ У ПАЦИЕНТОВ, ПОЛУЧАЮЩИХ ПЕРИТОНЕАЛЬНЫЙ ДИАЛИЗ
У пациентов с терминальной стадией хронической болезни почек (ХБП), получающих заместительную терапию перитонеальным диализом (ПД), частым осложнением является синдром белково-энергетической недостаточности (БЭН). Нутрит...
Лікування інфекцій сечової системи в умовах зростаючої антибіотикорезистентності: AntimicrobialStewardshipprogram
Лікування інфекцій сечової системи лімітується формуванням стійкості до антибактеріальних препаратів. Згідно звіту CDC у США реєструється близько 2 млн інфекцій та 25,000 смертельних випадків внаслідок антибіотико-резист...
Antioxidant effects of immunomodulators in patients with recurrent pyelonephritis
The purpose of our work was to investigate the effect of immunomodulatory medicines on the intensity of oxidative stress (OS), the cytokines level and the activity of renospecific enzymes in patients with recurrent pyelo...
Frequency of renal dysfunction in cardiac surgery patients and its effect on outcome
The purpose of this study was to define the frequency of renal dysfunction, including acute kidney injury (AKI), in cardiac surgery patients and its effect on outcome. Materials and methods. Patients 18 years old or old...
ЕФЕКТИВНІСТЬ ПРОБІОТИКУ З ЛАКТОБАКТЕРІЯМИ У ЗНИЖЕННІ ЕКСКРЕЦІЇ ОКСАЛАТУ ТА ПРОФІЛАКТИЦІ РЕЦИДИВУЮЧОГО ПІЄЛОНЕФРИТУ
Дане дослідження було проведено для оцінки здатності пробіотику із вмістом лактобактерій знижувати екскрецію оксалату та запобігатирецидивуванню пієлонефриту. Методи. Відкрите, 6–місячнерандомізоване контрольоване дослі...